ANTHRACYCLINE ENCAPSULATED WITH POLYSACCHARIDE FOR USE IN THE TREATMENT OF TUMOURS
The invention relates to a new form of a drug in the form of anthracycline encapsulated with a polysaccharide selected from epirubicin, daunorubicin, doxorubicin, idarubicin, especially encapsulated with dextran, for use in the treatment of specific tumours. L'invention concerne une nouvelle fo...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
12.09.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to a new form of a drug in the form of anthracycline encapsulated with a polysaccharide selected from epirubicin, daunorubicin, doxorubicin, idarubicin, especially encapsulated with dextran, for use in the treatment of specific tumours.
L'invention concerne une nouvelle forme d'un médicament sous la forme d'une anthracycline encapsulée avec un polysaccharide choisi parmi l'épirubicine, la daunorubicine, la doxorubicine, l'idarubicine, en particulier encapsulée avec du dextrane, destinée à être utilisée dans le traitement de tumeurs spécifiques. |
---|---|
Bibliography: | Application Number: WO2019PL50014 |